RTW INVESTMENTS, LP - CELLDEX THERAPEUTICS INC NEW ownership

CELLDEX THERAPEUTICS INC NEW's ticker is CLDXXXXX and the CUSIP is 15117B103. A total of 174 filers reported holding CELLDEX THERAPEUTICS INC NEW in Q4 2015. The put-call ratio across all filers is 1.37 and the average weighting 0.1%.

Quarter-by-quarter ownership
RTW INVESTMENTS, LP ownership history of CELLDEX THERAPEUTICS INC NEW
ValueSharesWeighting
Q1 2017$873,000
+2.9%
241,699
+0.8%
0.23%
-27.9%
Q4 2016$848,000
-83.1%
239,662
-80.7%
0.32%
-79.0%
Q3 2016$5,022,000
-9.5%
1,243,164
-1.7%
1.52%
-19.9%
Q2 2016$5,550,000
+48.4%
1,264,227
+27.8%
1.90%
+39.6%
Q1 2016$3,740,000
-62.6%
989,376
+55.3%
1.36%
-58.8%
Q4 2015$9,992,000
+31.9%
637,238
-11.3%
3.30%
+40.2%
Q3 2015$7,575,000
-36.3%
718,729
+52.4%
2.35%
-32.0%
Q2 2015$11,893,000471,5543.46%
Other shareholders
CELLDEX THERAPEUTICS INC NEW shareholders Q4 2015
NameSharesValueWeighting ↓
Ridgeback Capital Investments L.P. 1,025,000$24,815,00031.36%
TSP Capital Management Group, LLC 836,342$20,248,0008.80%
Iguana Healthcare Management, LLC 200,000$4,842,0002.76%
First Light Asset Management, LLC 116,096$2,811,0002.38%
SECTORAL ASSET MANAGEMENT INC 2,227,688$53,932,0002.33%
BENNETT LAWRENCE MANAGEMENT L L C/NY 550,735$13,334,0002.05%
Eventide Asset Management 257,000$6,222,0001.92%
Redmile Group, LLC 397,951$9,634,0001.19%
ARDSLEY ADVISORY PARTNERS LP 357,000$8,643,0001.15%
Rhenman & Partners Asset Management AB 90,000$2,179,0000.85%
View complete list of CELLDEX THERAPEUTICS INC NEW shareholders